Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2022-01-27 00:00:00 ET · period of report 2022-01-25 · accession 0000899243-22-003449 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-27 | 2022-01-25 | FATE | Valamehr Bahram | See Remarks | A - Grant | $0.00 | +33.3K | 179.8K | +23% | $0 |
| D | 2022-01-27 | 2022-01-25 | FATE | Valamehr Bahram | See Remarks | A - Grant | $0.00 | +53.1K | 53.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-25 | A | A | 33,302 | $0.00 | 179,834 | D | — | — | (F1) Award of restricted stock units that vest with respect to 1/4th of the underlying shares on each of January 8, 2023, January 8, 2024, January 8, 2025 and January 8, 2026, subject to the Reporting Person's continued service with the Issuer as of each such date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-01-25 | A | A | 53,058 | $0.00 | 53,058 | D | $39.87 · — to 2032-01-24 | 53,058 Common Stock | (F2) The shares subject to this option vest in 48 equal month installments beginning on February 1, 2022 such that this option will be fully exercisable on January 1, 2026, subject to the Reporting Person's continued service with the Issuer as of each such date. |